AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $24,000 | -29.4% | 37,306 | 0.0% | 0.03% | -32.6% |
| Q2 2022 | $34,000 | -30.6% | 37,306 | 0.0% | 0.05% | -19.3% |
| Q1 2022 | $49,000 | -78.9% | 37,306 | +42.9% | 0.06% | -80.3% |
| Q2 2021 | $232,000 | -55.4% | 26,114 | -30.0% | 0.29% | -36.8% |
| Q4 2020 | $520,000 | +7.0% | 37,306 | 0.0% | 0.46% | -33.1% |
| Q3 2020 | $486,000 | -25.3% | 37,306 | 0.0% | 0.69% | +3.2% |
| Q2 2020 | $651,000 | +12.2% | 37,306 | 0.0% | 0.66% | +58.0% |
| Q1 2020 | $580,000 | – | 37,306 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |